| A group of antiabortion doctors challenged the FDA's regulation of mifepristone, used in more than 60 percent of U.S. abortions. Since the high court overturned Roe v. Wade in 2022, abortion medications have grown increasingly important but have faced court challenges. | 
No comments:
Post a Comment